WHO recommendations on antenatal care for a positive pregnancy experience

Recommendations

Info

<strong>WHO</strong> <strong>recommendations</strong> on antenatal care for a positive pregnancy experience 206. Pattinson R. 2016. Audit of Mpumalanga stillbirths. Presentation at ANC guideline development group meeting (21–23 March). Geneva: World Health Organization; 2016. 207. Gurol I, Scheel I. Adoption and implementation of ANC guidelines at large scale. Presentation at ANC guideline development group meeting (21– 23 March). Geneva: World Health Organization; 2016. 208. Conrad P, Schmid G, Tientrebeogo J, Moses A, Kirenga S, Neuhann F et al. Compliance with focused antenatal care services: do health workers in rural Burkina Faso, Uganda and Tanzania perform all ANC procedures? Trop Med Int Health. 2012;17:300–7. doi:10.1111/j.1365- 3156.2011.02923.x. 209. Nyarko P, Birungi H, Armar-Klamesu M, Arhinful D, Degarnus S, Odoi-Agyarko H, Brew G. Acceptability and feasibility of introducing the <strong>WHO</strong> focused antenatal care package in Ghana. FRONTIERS final report. Washington (DC): Population Council; 2006 (http://citeseerx.ist.psu.edu/viewdoc/ download?rep=rep1&type=pdf&doi=10.1.1.175. 8828, accessed 28 September 2016). 210. Birungi H, Onyango-Ouma W. Acceptability and sustainability of the <strong>WHO</strong> focused antenatal care package in Kenya. Frontiers in Reproductive Health Program, Population Council; 2006 (http://citeseerx.ist.psu.edu/viewdoc/ download?doi=10.1.1.175.8488&rep=rep1&type= pdf, accessed 28 September 2016). 211. Von Both C, Fleßa S, Makuwani A, Mpembeni R, Albrecht J. How much time do health services spend on antenatal care? Implications for the introduction of the focused antenatal care model in Tanzania. BMC Pregnancy Childbirth. 2006;6:22. 212. Filby A, McConville F, Portela A. What prevents quality midwifery care? A systematic mapping of barriers in low and middle income countries from the provider perspective. PLoS One. 2016;11(5): e153391. doi:10.1371/journal.pone.0153391. 213. AGREE II-Global Rating Scale (GRS) Instrument. AGREE Enterprise; 2016 (http://www.agreetrust. org/resource-centre/agree-ii-grs-instrument/, accessed 28 October 2016). 214. GREAT Network [website]. GREAT Network; 2016 (http://greatnetworkglobal.org/, accessed 27 October 2016). 136
Annex 1: External experts and <strong>WHO</strong> staff involved in the preparation of this guideline <strong>WHO</strong> Steering Group (Geneva, Switzerland) A. Metin Gülmezoglu Coordinator Department of Reproductive Health and Research Maternal and Perinatal Health & Preventing Unsafe Abortion Team Matthews Mathai Coordinator Department of Maternal, Newborn, Child and Adolescent Health Epidemiology, Monitoring and Evaluation Team Olufemi T. Oladapo Medical Officer Department of Reproductive Health and Research Maternal and Perinatal Health & Preventing Unsafe Abortion Team Juan Pablo Peña-Rosas Coordinator Department Nutrition for Health and Development Evidence and Programme Guidance Team Özge Tunçalp Scientist Department of Reproductive Health and Research Maternal and Perinatal Health & Preventing Unsafe Abortion Team Guideline Development Group (GDG) Jim Neilson (CHAIR) Dundee, United Kingdom Mohammed Ariful Alam Programme Coordinator BRAC Health Nutrition & Population Program BRAC Center Dhaka, Bangladesh Françoise Cluzeau Associate Director NICE International National Institute for Health and Care Excellence (NICE) London, United Kingdom Luz Maria De-Regil Director, Research and Evaluation & Chief Technical Advisor Micronutrient Initiative Ottawa, Canada Atf Ghérissi Assistant Professor Ecole Supérieure des Sciences et Techniques de la Santé de Tunis (ESSTST) El Manar, Tunisia Gill Gyte Patient Representative Cochrane Pregnancy and Childbirth Group Liverpool Women’s NHS Foundation Trust Liverpool, United Kingdom Rintaro Mori Director Department of Health Policy National Research Institute for Child Health and Development Tokyo, Japan Lynnette Neufeld Director Monitoring, Learning and Research Global Alliance for Improved Nutrition (GAIN) Geneva, Switzerland Lisa M. Noguchi Senior Maternal Health Advisor Maternal and Child Survival Program Washington, DC, USA Nafissa Osman Head Academic Department of Obstetrics and Gynaecology Faculty of Medicine Eduardo Mondlane University Maputo, Mozambique Erika Ota Researcher National Center for Child Health and Development Tokyo, Japan Annex 1: External experts and <strong>WHO</strong> staff 137
Page 1:
WHO recomm
Page 4 and 5:
WHO Library Catalo
Page 6 and 7:
« To achieve the Every Woman Every
Page 8 and 9:
Funding was provided for this guide
Page 10 and 11:
WHO recomm
Page 12 and 13:
Evaluation (GRADE) and Confidence i
Page 14 and 15:
Zinc supplements Multiple micronutr
Page 16 and 17:
Ultrasound scan Doppler ultrasound
Page 18 and 19:
Task shifting components of antenat
Page 20 and 21:
expect from ANC is to have a “pos
Page 22 and 23:
2. Methods WHO <st
Page 24 and 25:
a list of ANC outcomes was prioriti
Page 26 and 27:
content experts among the GDG membe
Page 28 and 29:
• nFeasibility: Feasibility is in
Page 30 and 31:
are indicated by a footnote in the
Page 32 and 33:
A. Nutritional interventions <stron
Page 34 and 35:
WHO recomm
Page 36 and 37:
A.1.2: Nutrition education on energ
Page 38 and 39:
A.1.3: Energy and protein dietary s
Page 40 and 41:
A.1.4: High-protein supplements REC
Page 42 and 43:
WHO recomm
Page 44 and 45:
Summary of evidence and considerati
Page 46 and 47:
WHO recomm
Page 48 and 49:
WHO recomm
Page 50 and 51:
Equity Effective interventions to i
Page 52 and 53:
A.7: Vitamin B6 (pyridoxine) supple
Page 54 and 55:
only a quarter of the planned sampl
Page 56 and 57:
A.10: Restricting caffeine intake R
Page 58 and 59:
B. Maternal and fetal assessment B.
Page 60 and 61:
WHO recomm
Page 62 and 63:
to produce results than urine dipst
Page 64 and 65:
WHO recomm
Page 66 and 67:
B.1.4: Gestational diabetes mellitu
Page 68 and 69:
B.1.6: Substance use RECOMMENDATION
Page 70 and 71:
on screening, please refer to the 2
Page 72 and 73:
Women’s values A scoping review o
Page 74 and 75:
B.2.2: Symphysis-fundal height (SFH
Page 76 and 77:
B.2.4: Ultrasound scan RECOMMENDATI
Page 78 and 79:
WHO recomm
Page 80 and 81:
are willing to be screened and test
Page 82 and 83:
Women’s values A scoping review o
Page 84 and 85:
WHO recomm
Page 86 and 87:
C.4: Preventive anthelminthic treat
Page 88 and 89:
C.5: Tetanus toxoid vaccination REC
Page 90 and 91:
C.6: Intermittent preventive treatm
Page 92 and 93:
D. Interventions for common physiol
Page 94 and 95:
WHO recomm
Page 96 and 97:
Values See “Women’s values” a
Page 98 and 99:
D.4: Interventions for low back and
Page 100 and 101:
Acceptability Qualitative evidence
Page 102 and 103:
Additional considerations • nComp
Page 104 and 105: WHO recomm
Page 106 and 107: Senegal, Sri Lanka, Yemen and Zambi
Page 116 and 117: may help to address inequalities. H
Page 118 and 119: E.6: Recruitment and retention of s
Page 122 and 123: visits (high confidence in the evid
Page 136 and 137: 5. Research implications During the
Page 138 and 139: 6. Dissemination, applicability and
Page 140 and 141: espectively. Any concern about the
Page 148 and 149: 105. Systematic screening for activ
Page 158 and 159: WHO headquarters (
Page 162 and 163: Dr Erika Ota Nutrition, evidence sy
Page 170: WHO recomm
show all

WHO recommendations on antenatal care for a positive pregnancy experience

Create successful ePaper yourself

Delete template?

Save as template?